Popular Pre-Market Trades in US Stocks
Vertiv is down 3.05% in pre-market trading. Based on recent key news:
<ol>
<li>
On December 10, Vertiv reported strong quarterly performance, healthy demand, and an optimistic EPS outlook, driving the stock price up. However, the market expressed concerns about the upside potential of its valuation, leading to a pre-market decline in stock price.
</li>
<li>
On December 9, Citigroup raised Vertiv's target price from $198 to $220, showing market confidence in its future growth, but analysts rated it as a moderate buy and did not include it in the top recommendations.
</li>
<li>
On December 11, global markets were fragile due to the intertwining of geopolitical and economic policies. Investors need to pay attention to the U.S. Supreme Court's ruling on the legality of tariffs and its impact, which may lead to market volatility. The investment direction in the industrial sector is clear, and attention should be paid to Federal Reserve policies.
</li>
</ol>
Top Gainers in Pre-Market Trading in US Stocks
Jiuzi is up 79.40% in pre-market trading. Based on recent news:
<ol>
<li>
On December 12, Jiuzi Holdings announced plans to expand its private placement financing scale to $1 billion to support the development of its cryptocurrency business. This news triggered a strong market reaction, driving the stock price significantly higher.
</li>
<li>
On December 12, Jiuzi Holdings disclosed in Hangzhou that it had signed a memorandum of understanding with institutional investors, planning to raise up to $1 million through this agreement, further enhancing market confidence.
</li>
<li>
On December 9, Jiuzi Holdings announced a 1-for-40 reverse stock split. Although the stock price experienced fluctuations in the short term, it is expected to help improve the company's stock market performance in the long run. The cryptocurrency asset industry has recently performed strongly, attracting significant investment.
</li>
</ol>
cbdMD is up 38.42% in pre-market trading. Based on recent key news:
<ol>
<li>
On December 8, cbdMD announced that it had resumed compliance with the continued listing standards of NYSE American. The company resolved all deficiencies related to NYSE American Company Guide Sections 1003(a)(i) and (ii), leading to an increase in stock price. Source: Company announcement
</li>
<li>
On December 9, cbdMD's stock price rose to $0.62, an increase of 1.63934%. This rise is related to the company's restored compliance status, enhancing market confidence. Source: Company announcement
</li>
<li>
No other significant news recently. Industry compliance has improved, and market confidence has strengthened.
</li>
</ol>
Sihong Group is up 30.65% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, this stock shows significant volatility, and the specific reasons need further observation

Vertiv pre-market down 3.05%; Jiuzi pre-market up 79.40%; cbdMD pre-market up 38.42%; SiHong Group pre-market up 30.65%

Pre-market hot trades in US stocks: Vertiv pre-market down 3.05%, valuation concerns outweigh performance benefits